| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Pursley James | President | C/O HINGE HEALTH, INC., 455 MARKET STREET, SUITE 700, SAN FRANCISCO | /s/ James Budge, Attorney-in-Fact | 24 Nov 2025 | 0001783108 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HNGE | Class A Common Stock | Sale | $120,376 | -2,714 | -0.34% | $44.35 | 802,190 | 21 Nov 2025 | Direct | F1, F2 |
| transaction | HNGE | Class A Common Stock | Sale | $426,965 | -9,332 | -1.2% | $45.75 | 792,856 | 21 Nov 2025 | Direct | F1, F3 |
| transaction | HNGE | Class A Common Stock | Sale | $136,145 | -2,954 | -0.37% | $46.09 | 789,902 | 21 Nov 2025 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. |
| F2 | Represents the weighted average sale price. The lowest price at which shares were sold was $43.96 and the highest price at which shares were sold was $44.94. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. |
| F3 | Represents the weighted average sale price. The lowest price at which shares were sold was $45.01 and the highest price at which shares were sold was $46.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. |
| F4 | Represents the weighted average sale price. The lowest price at which shares were sold was $46.01 and the highest price at which shares were sold was $46.21. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. |